LeMaitre Vascular, Inc.

LMAT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Market Cap$1,982,977$1,878,093$1,893,623$2,073,703
- Cash$25,494$27,177$25,340$25,610
+ Debt$185,632$185,889$185,361$185,685
Enterprise Value$2,143,115$2,036,805$2,053,644$2,233,778
Revenue$61,046$64,232$59,871$55,717
% Growth-5%7.3%7.5%
Gross Profit$45,955$44,974$41,420$38,590
% Margin75.3%70%69.2%69.3%
EBITDA$26,483$22,017$18,083$20,156
% Margin43.4%34.3%30.2%36.2%
Net Income$17,362$13,779$11,011$11,184
% Margin28.4%21.5%18.4%20.1%
EPS Diluted0.750.60.480.49
% Growth25%25%-2%
Operating Cash Flow$28,764$20,291$9,039$15,182
Capital Expenditures-$2,281-$1,342-$1,383-$2,044
Free Cash Flow$26,483$18,949$7,656$13,138
LeMaitre Vascular, Inc. (LMAT) Financial Statements & Key Stats | AlphaPilot